Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities.

The Centers for Disease Control and Prevention (CDC), under the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), has announced a forecasted funding opportunity titled "Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities." This grant aims to address parasitic infections by supporting initiatives grounded in evidence-based practices, reflecting the CDC’s overarching mission to safeguard public health and reduce disease burden across communities. The primary objective of this opportunity is to mitigate the impact of parasitic diseases through prevention and control activities that are scientifically validated and adaptable to varying population needs across the United States. This may include surveillance, diagnostics, public education, clinical outreach, and support for treatment accessibility. The scope is expected to cover multiple parasitic pathogens and target both endemic and emerging threats through coordinated local, state, and national-level interventions. Funded through cooperative agreements, the program offers an estimated total of $23.75 million with anticipated awards ranging from $250,000 to $1.25 million. The CDC expects to fund approximately 11 recipients. This structure suggests a collaborative approach where the CDC maintains substantial involvement in supported projects. While cost-sharing is not required, the comprehensive nature of this initiative will likely necessitate strategic partnerships and strong organizational capacity among grantees. Eligible applicants include a broad range of entities: state and local governments, federally and non-federally recognized tribal governments and organizations, public and private institutions of higher education, nonprofits (both with and without 501(c)(3) status), independent school districts, housing authorities, for-profit organizations, and small businesses. Bona fide agents acting on behalf of eligible governmental units are also permitted to apply, further expanding access to this critical public health funding. The estimated timeline begins with a projected post date of April 6, 2026, and an application due date of June 5, 2026, by 11:59 p.m. Eastern Time. Awards are anticipated by August 31, 2026, with projects expected to commence on September 30, 2026. This opportunity is forecasted as of December 10, 2025, and follows a discretionary funding category under CFDA 93.084—Prevention of Disease, Disability, and Death by Infectious Diseases. Applicants or interested parties can reach out to the designated CDC project officer, Jamal Choice, via email at qhi2@cdc.gov or phone at 404-718-8228. While no specific application components or evaluation criteria have been released in this forecast, applicants should monitor for the official Notice of Funding Opportunity (NOFO) upon release to review submission requirements, expected outcomes, and performance metrics.